Recruiting

Topical B12

Sponsor:

Spartanburg Regional Healthcare System

Code:

NCT00465699

Conditions

Eczema

Eligibility Criteria

Sex: All

Age: 0 - 18

Healthy Volunteers: Accepted

Interventions

Topical B12 0.07%

Study Details

Brief summary:

This study is being done to see in B12 applied to the skin will improve the symptoms of eczema in children compared to a placebo creme

Conditions

Eczema

Study ID

NCT00465699

Start date

Apr, 2007

Status verified date

Apr, 2007

Completion date

Apr, 2007

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0 - 18

Healthy Volunteers: Accepted

Inclusion Criteria:

  • children presenting to the Center for Family Medicine or Regional Pediatrics between the ages of 6 months and 18 years old with atopic dermatitis

Exclusion Criteria:

  • unwillingness of parent to consent to study protocol, pregnancy or lactation, eczema with superinfection present, known history of allergy to Vitamin B12 or components of the base cream, topical treatment with corticosteroids in the 4 weeks prior to enrollment

Study Design

Enrollment

50 participants

Allocation

Randomized

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Interventions

Topical B12 0.07%

Primary outcome measure

  • Reduction in SCORAD at 2 and 4 weeks [ Time Frame: undefined ]

Central Contacts and Locations

Central contacts

Locations

Center for Family Medicine

Recruiting

Spartanburg, South Carolina, United States, 29303

Principal Investigator:

Ronald P Januchowski, D.O.

More Information

Sponsor

Spartanburg Regional Healthcare System

Last update posted

Apr 25, 2007

Last verified

Apr, 2007

Keywords

  • Eczema
  • Pediatric
  • Vitamin B12

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Spartanburg Regional Healthcare System on 2007-04-25.